Idexx Laboratories Inc vs Eli Lilly & Co.
IDXX vs LLY — side-by-side comparison from reported financials. IDXX leads 4, LLY leads 7 of 11 comparable metrics.
Idexx Laboratories Inc
IDXX · Healthcare
$518.00+0.95%Solid
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | IDXX | LLY |
|---|---|---|
| Price | $518.00 | $1 177.20 |
| Market cap | $40.8B | $1.05T |
| Revenue (TTM) | $4.55B | $79.7B |
| Revenue growth | +8.5% | +31.7% |
| Net margin | 25.0% | 33.5% |
| Free cash flow | $1.25B | $18.2B |
| Net cash (debt) | ($195M) | ($35.2B) |
| 1-year price return | -17.6% | +37.6% |
| P/E | 35.8 | 41.6 |
| P/E vs own history (cheap-side %) | 99% | 88% |
| Dividend yield | — | 0.52% |
| Return on equity | 72% | 93% |
| Altman Z-score | 17.91 | 7.10 |
| CV checks passed | 10 of 10 | 11 of 10 |
| Employees | 11,000 | 50,000 |
Full résumé-style profiles: IDXX CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.